• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Guselkumab as a treatment option for recalcitrant pyoderma gangrenosum.

作者信息

Baier Cassandra, Barak Orr

机构信息

Pennsylvania Dermatology Partners, Pottstown, Pennsylvania.

出版信息

JAAD Case Rep. 2020 Dec 14;8:43-46. doi: 10.1016/j.jdcr.2020.12.005. eCollection 2021 Feb.

DOI:10.1016/j.jdcr.2020.12.005
PMID:33490346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7810910/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/7810910/62d97b63fab3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/7810910/0ad63c5e6d57/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/7810910/62d97b63fab3/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/7810910/0ad63c5e6d57/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c97/7810910/62d97b63fab3/gr2.jpg

相似文献

1
Guselkumab as a treatment option for recalcitrant pyoderma gangrenosum.古塞库单抗作为治疗顽固性坏疽性脓皮病的一种选择。
JAAD Case Rep. 2020 Dec 14;8:43-46. doi: 10.1016/j.jdcr.2020.12.005. eCollection 2021 Feb.
2
Modified dose of guselkumab for treatment of pyoderma gangrenosum.用于治疗坏疽性脓皮病的古塞库单抗改良剂量
JAAD Case Rep. 2022 Jan 6;21:38-42. doi: 10.1016/j.jdcr.2021.11.030. eCollection 2022 Mar.
3
Recalcitrant cutaneous pyoderma gangrenosum with pulmonary involvement resolved with treatment of underlying plasma cell dyscrasia.伴有肺部受累的顽固性皮肤坏疽性脓皮病经潜在浆细胞发育异常的治疗后得以缓解。
JAAD Case Rep. 2021 Jan 12;9:28-30. doi: 10.1016/j.jdcr.2020.12.028. eCollection 2021 Mar.
4
Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report.乌司奴单抗治疗顽固性坏疽性脓皮病：一例报告
SAGE Open Med Case Rep. 2019 May 2;7:2050313X19845206. doi: 10.1177/2050313X19845206. eCollection 2019.
5
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病：英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
6
Pyoderma Gangrenosum Over Hypertrophic Scar: Report of a Rare Presentation.肥厚性瘢痕上的坏疽性脓皮病：罕见表现病例报告
Indian Dermatol Online J. 2020 Mar 9;11(2):222-225. doi: 10.4103/idoj.IDOJ_153_19. eCollection 2020 Mar-Apr.
7
Portable negative-pressure wound therapy for pyoderma gangrenosum: Report of two cases.便携式负压伤口治疗坏疽性脓皮病：两例报告。
J Dermatol. 2018 Apr;45(4):483-486. doi: 10.1111/1346-8138.14180. Epub 2017 Dec 13.
8
What do autoinflammatory syndromes teach about common cutaneous diseases such as pyoderma gangrenosum? A commentary.自身炎症性疾病对常见皮肤疾病（如坏疽性脓皮病）有何启示？评论。
Dermatol Clin. 2013 Jul;31(3):427-35. doi: 10.1016/j.det.2013.04.004. Epub 2013 May 10.
9
Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum.影响难治性坏疽性脓皮病静脉注射免疫球蛋白治疗反应的临床因素。
J Dermatolog Treat. 2020 Nov;31(7):723-726. doi: 10.1080/09546634.2019.1606888. Epub 2019 May 6.
10
Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab.白细胞介素23在坏疽性脓皮病中的表达及乌司奴单抗靶向治疗
Arch Dermatol. 2011 Oct;147(10):1203-5. doi: 10.1001/archdermatol.2011.168. Epub 2011 Jun 16.

引用本文的文献

1
Guselkumab - In Psoriasis and Beyond.古塞库单抗——用于银屑病及其他病症
Dermatol Pract Concept. 2024 Jul 1;14(3):e2024181. doi: 10.5826/dpc.1403a181.
2
Monoclonal Antibodies in the Management of Inflammation in Wound Healing: An Updated Literature Review.单克隆抗体在伤口愈合炎症管理中的应用：文献综述更新
J Clin Med. 2024 Jul 12;13(14):4089. doi: 10.3390/jcm13144089.
3
The Pathophysiology and Treatment of Pyoderma Gangrenosum-Current Options and New Perspectives.坏疽性脓皮病的发病机制和治疗：现有选择和新视角。

本文引用的文献

1
Recent advances in managing and understanding pyoderma gangrenosum.坏疽性脓皮病管理与认识的最新进展
F1000Res. 2019 Dec 12;8. doi: 10.12688/f1000research.19909.1. eCollection 2019.
2
Pyoderma gangrenosum - a guide to diagnosis and management .坏疽性脓皮病—诊断与治疗指南
Clin Med (Lond). 2019 May;19(3):224-228. doi: 10.7861/clinmedicine.19-3-224.
3
Ustekinumab for the treatment of recalcitrant pyoderma gangrenosum: A case report.乌司奴单抗治疗顽固性坏疽性脓皮病：一例报告
Int J Mol Sci. 2024 Feb 19;25(4):2440. doi: 10.3390/ijms25042440.
4
New treatment of pyoderma gangrenosum and hidradenitis suppurativa: A review.坏疽性脓皮病和化脓性汗腺炎的新治疗方法：综述。
J Dermatol. 2024 Feb;51(2):172-179. doi: 10.1111/1346-8138.17031. Epub 2023 Nov 27.
5
Recalcitrant Ulcerative Pyoderma Gangrenosum of the Leg Responsive to Tildrakizumab: A Case Report.对替拉珠单抗有反应的腿部顽固性溃疡性坏疽性脓皮病：一例报告
Clin Cosmet Investig Dermatol. 2022 Aug 23;15:1729-1736. doi: 10.2147/CCID.S374534. eCollection 2022.
6
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments.坏疽性脓皮病：已确立和新兴药物治疗的最新文献综述。
Am J Clin Dermatol. 2022 Sep;23(5):615-634. doi: 10.1007/s40257-022-00699-8. Epub 2022 May 24.
7
Modified dose of guselkumab for treatment of pyoderma gangrenosum.用于治疗坏疽性脓皮病的古塞库单抗改良剂量
JAAD Case Rep. 2022 Jan 6;21:38-42. doi: 10.1016/j.jdcr.2021.11.030. eCollection 2022 Mar.
SAGE Open Med Case Rep. 2019 May 2;7:2050313X19845206. doi: 10.1177/2050313X19845206. eCollection 2019.
4
Interleukin 23 expression in pyoderma gangrenosum and targeted therapy with ustekinumab.白细胞介素23在坏疽性脓皮病中的表达及乌司奴单抗靶向治疗
Arch Dermatol. 2011 Oct;147(10):1203-5. doi: 10.1001/archdermatol.2011.168. Epub 2011 Jun 16.
5
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial.英夫利昔单抗治疗坏疽性脓皮病：一项随机、双盲、安慰剂对照试验。
Gut. 2006 Apr;55(4):505-9. doi: 10.1136/gut.2005.074815. Epub 2005 Sep 27.